Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiomyopathies clinical trials
Every US clinical trial registered for Cardiomyopathies — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
18 US clinical trials · 13 currently recruiting
The research picture
Cardiomyopathies has 18 registered US clinical trials, 13 of them open to new participants right now — about 72% of the total.
- 13
- recruiting participants now
- 72%
- of trials open to enrollment
- 2
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Mayo Clinic
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Johns Hopkins University
NCT00733590
Mayo AVC Registry and Biobank
Mayo Clinic
NCT03049254
Genetic Markers of Cardiovascular Disease in Epilepsy
Mayo Clinic
NCT02824822
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
NCT06563895
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
Tulane University
NCT04843371
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Zoll Medical Corporation
NCT04504188
Pediatric Cardiomyopathy Mutation Analysis
Indiana University
NCT02432092
Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation
Stanford University
NCT05617547
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
University of Rochester
NCT05034432
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Stanford University
NCT06080074
PKP2-ACM Natural History Study
Rocket Pharmaceuticals
NCT06644742
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Weill Medical College of Cornell University
NCT05302271
Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern
University of Rochester
NCT06977217
Edema and Fibrosis CMR Imaging in Cardiomyopathy
University of Pennsylvania
NCT03534726
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
Abbott Medical Devices
NCT00121485
Cardio-pulmonary Rehabilitation and Sleep Quality
MetroHealth Medical Center
NCT04668599
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Abramson Cancer Center at Penn Medicine
NCT04023110
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Cardiomyopathies Trial Landscape
ClinicalTrials.gov lists 18 US studies indexed under Cardiomyopathies, and 13 of those are currently open to recruitment — roughly 72% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Cardiomyopathies shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Cardiomyopathies is led by Mayo Clinic with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 18 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Cardiomyopathies?
PlainTrial tracks 18 US clinical trials for Cardiomyopathies, of which 13 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cardiomyopathies?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.